Participating Mentors
Below is a list of mentors for the CURATE program. This list represents a selection of faculty who may mentor students in the program and is not exhaustive. Mentor assignments will be determined based on students’ interests and available research opportunities.
Please note: Students do not need to contact potential mentors prior to or after submitting an application. The CURATE program team will ultimately match selected students with available mentors
Managing opioid use disorders and safer and more competent opioid prescribing for managing pain
Engagement of young adults who use drugs and their families in care to minimize risk for overdose and the complications of drug use
Obstetrics and Gynecology, Maternal Health and Addiction Medicine
Substance use disorders with an emphasis on evaluation research with community partners providing addiction treatment services
Innovative treatment models for opioid use disorder in marginalized populations and interventions on social determinants of health, such as food insecurity. Also, racism and health care, particularly its manifestations in medical education and training
Social determinants of health, with a focus on how features of the social and built environment, especially health policies, create disparities in health and health care utilization among people with or at increased risk for HIV
The intersection of women’s health and substance use, including increasing sexual, reproductive, and HIV prevention services in substance use treatment spaces; substance use treatment while pregnant and parenting; and gender-responsive harm reduction
Improving the understanding and care of patients with co-morbid substance use disorders and chronic pain as well as studying health literacy and health communication techniques to improve care of vulnerable patients
The impact of housing instability, depression, and substance use on access to care for people with HIV infection; defining and measuring the quality of medical care on addiction outcomes; screening and brief intervention for unhealthy alcohol and drug use in general medical settings
The safety of opioid prescribing and the recognition and treatment of opioid use disorders
Hepatitis-C virus (HCV) infection and HCV/HIV co-infection comparative- and cost-effectiveness research using computational biology, clinical epidemiology and clinical economics methods
Access to quality care for disadvantaged people; stigma, HIV prevention, and care in key populations; behavioral interventions in humanitarian settings; implementation Science; global maternal and newborn health
Understanding the cognitive-motivational processes underlying health risk behaviors (e.g., hazardous/harmful drinking, substance use, risky sexual decisions) and developing psychological interventions to reduce these risks
Alcohol and drug use, HIV infection, primary medical care
Substance use and chronic infections like human immunodeficiency virus (HIV), and tuberculosis (TB) and how these exposures impact the heart, liver and lungs
The health and well-being of marginalized persons, particularly sexual and gender minority populations (e.g., lesbian, gay, bisexual, transgender, and queer [LGBTQ] persons)
Access and utilization of primary care and substance use services in low-income populations
The medical complications of substance use, specifically HIV and overdose; the opioid crisis and the integration of addiction specialty care and general medical care; community overdose interventions, including post-overdose outreach programs and overdose prevention hotlines
Inpatient addiction care, long-term Office-Based Addiction Treatment (OBAT) with buprenorphine
Improving initiation and access to medications for opioid use disorder in the emergency department (ED) with an equity lens, ensuring smooth transitions of care from the ED to outpatient settings, and integrating a harm reduction approach into the care of patients in the ED
Decreasing risk associated with substance use for youth, preventing substance use disorders in youth with psychiatric disorders, and treatment of co-occurring psychiatric and substance use disorders